Repotrectinib in a Patient With <i>NTRK</i> Fusion-Positive Pancreatic Carcinoma and Congenital Long QT Syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 38271657.
- Also identified by DOI 10.1200/PO.23.00265 and PMC identifier 10830087.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Repotrectinib in a patient with NTRK fusion-positive pancreatic carcinoma and congenital long QT syndrome.
Medical subject headings
- Pancreatic Neoplasms
- Long QT Syndrome
- Macrocyclic Compounds